Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics. 2010

Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

BACKGROUND The antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (HCC) in patients with liver cirrhosis. It might also be effective in noncirrhotic HCC provided that the angiogenic properties of both tumor types are comparable. The aim of this study is to compare endothelial cell dynamics, microvessel density (MVD), and vessel maturation as indirect markers of angiogenesis in human HCC in cirrhotic and noncirrhotic livers. METHODS In a tertiary care setting, 70 consecutive HCC tumors were analyzed for endothelial cell dynamics. CD34 was applied to identify tumor microvessels, double immunolabeling Ki67/CD34 and activated caspase-3/CD34 to assess endothelial cell proliferation and apoptosis, and alpha-smooth muscle actin/CD34 for pericyte coverage. These characteristics were compared in cirrhotic (n = 33) and noncirrhotic HCCs (n = 37). Microvessel density was correlated with radiological signs of hypervascularity as obtained with dynamic four-phase CT scans during the arterial and portal phase of contrast enhancement. RESULTS Microvessels in cirrhotic and noncirrhotic HCC were mainly mature. In both groups endothelial cell turnover was low and MVD was not different. There was no correlation between MVD and venous invasion, tumor size, and turnover of tumor cells or endothelial cells. MVD was negatively correlated with contrast washout in the portal venous phase of CT scanning. In transplanted patients, MVD was not correlated with survival, whereas in patients after liver resection a high MVD was associated with a better prognosis. CONCLUSIONS Angiogenic characteristics of HCC in cirrhotic and noncirrhotic livers have a remarkable similarity.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic

Related Publications

Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
January 1999, Radiology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
January 1998, Clinical imaging,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
February 1997, American journal of clinical pathology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
October 1998, Investigative radiology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
January 1996, American journal of clinical pathology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
March 2023, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
February 2010, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
April 1979, Experimental and molecular pathology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
March 2016, European journal of gastroenterology & hepatology,
Wenjiao Zeng, and Annette S H Gouw, and Marius C van den Heuvel, and Grietje Molema, and Sibrand Poppema, and Eric J van der Jagt, and Koert P de Jong
August 2013, Journal of clinical pathology,
Copied contents to your clipboard!